vs
La Rosa Holdings Corp.（LRHC）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
La Rosa Holdings Corp.的季度营收约是TriSalus Life Sciences, Inc.的1.5倍（$20.2M vs $13.2M），La Rosa Holdings Corp.净利率更高（-27.4% vs -73.9%，领先46.5%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 3.2%），过去两年La Rosa Holdings Corp.的营收复合增速更高（72.5% vs 43.0%）
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
LRHC vs TLSI — 直观对比
营收规模更大
LRHC
是对方的1.5倍
$13.2M
营收增速更快
TLSI
高出56.7%
3.2%
净利率更高
LRHC
高出46.5%
-73.9%
两年增速更快
LRHC
近两年复合增速
43.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.2M | $13.2M |
| 净利润 | $-5.5M | $-9.8M |
| 毛利率 | 8.4% | 86.7% |
| 营业利润率 | -24.7% | -24.8% |
| 净利率 | -27.4% | -73.9% |
| 营收同比 | 3.2% | 59.8% |
| 净利润同比 | -125.7% | 3.5% |
| 每股收益（稀释后） | $-5.44 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LRHCTLSI
| Q4 25 | — | $13.2M | ||
| Q3 25 | $20.2M | $11.6M | ||
| Q2 25 | $23.2M | $11.2M | ||
| Q1 25 | $17.5M | $9.2M | ||
| Q4 24 | $17.7M | $8.3M | ||
| Q3 24 | $19.6M | $7.3M | ||
| Q2 24 | $19.1M | $7.4M | ||
| Q1 24 | $13.1M | $6.5M |
净利润LRHCTLSI
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-5.5M | $-10.8M | ||
| Q2 25 | $78.4M | $-8.3M | ||
| Q1 25 | $-95.7M | $-10.4M | ||
| Q4 24 | $-5.1M | $-10.1M | ||
| Q3 24 | $-2.5M | $-2.4M | ||
| Q2 24 | $-2.3M | $-4.3M | ||
| Q1 24 | $-4.6M | $-13.2M |
毛利率LRHCTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | 8.4% | 83.5% | ||
| Q2 25 | 8.0% | 83.9% | ||
| Q1 25 | 8.8% | 83.7% | ||
| Q4 24 | 8.9% | 85.3% | ||
| Q3 24 | 8.3% | 86.3% | ||
| Q2 24 | 8.3% | 87.6% | ||
| Q1 24 | 8.9% | 85.0% |
营业利润率LRHCTLSI
| Q4 25 | — | -24.8% | ||
| Q3 25 | -24.7% | -77.9% | ||
| Q2 25 | -10.6% | -65.4% | ||
| Q1 25 | -26.7% | -79.9% | ||
| Q4 24 | -17.1% | -91.8% | ||
| Q3 24 | -8.9% | -118.9% | ||
| Q2 24 | -9.7% | -111.0% | ||
| Q1 24 | -35.0% | -180.8% |
净利率LRHCTLSI
| Q4 25 | — | -73.9% | ||
| Q3 25 | -27.4% | -93.5% | ||
| Q2 25 | 337.8% | -73.9% | ||
| Q1 25 | -546.5% | -113.2% | ||
| Q4 24 | -28.7% | -122.4% | ||
| Q3 24 | -12.5% | -32.6% | ||
| Q2 24 | -12.2% | -58.8% | ||
| Q1 24 | -35.1% | -204.5% |
每股收益（稀释后）LRHCTLSI
| Q4 25 | — | $-0.22 | ||
| Q3 25 | $-5.44 | $-0.96 | ||
| Q2 25 | $15.25 | $-0.27 | ||
| Q1 25 | $-5.86 | $-0.39 | ||
| Q4 24 | $28.54 | $-0.38 | ||
| Q3 24 | $-16.49 | $-0.12 | ||
| Q2 24 | $-12.49 | $-0.21 | ||
| Q1 24 | $-0.35 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $20.4M |
| 总债务越低越好 | $642.8K | — |
| 股东权益账面价值 | $1.6M | $-33.9M |
| 总资产 | $21.7M | $35.3M |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势，按日历期对齐
现金及短期投资LRHCTLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | $4.0M | $22.7M | ||
| Q2 25 | $5.1M | $26.5M | ||
| Q1 25 | $2.9M | $13.0M | ||
| Q4 24 | $1.4M | $8.5M | ||
| Q3 24 | $1.8M | $11.3M | ||
| Q2 24 | $1.6M | $16.5M | ||
| Q1 24 | $1.1M | $4.0M |
总债务LRHCTLSI
| Q4 25 | — | — | ||
| Q3 25 | $642.8K | — | ||
| Q2 25 | $644.3K | — | ||
| Q1 25 | $645.9K | — | ||
| Q4 24 | $647.6K | — | ||
| Q3 24 | $649.2K | — | ||
| Q2 24 | $650.8K | — | ||
| Q1 24 | $652.4K | — |
股东权益LRHCTLSI
| Q4 25 | — | $-33.9M | ||
| Q3 25 | $1.6M | $-26.7M | ||
| Q2 25 | $3.4M | $-19.4M | ||
| Q1 25 | $-87.5M | $-34.4M | ||
| Q4 24 | $2.6M | $-25.9M | ||
| Q3 24 | $5.0M | $-20.4M | ||
| Q2 24 | $4.7M | $-25.3M | ||
| Q1 24 | $5.6M | $-36.0M |
总资产LRHCTLSI
| Q4 25 | — | $35.3M | ||
| Q3 25 | $21.7M | $36.5M | ||
| Q2 25 | $22.9M | $41.3M | ||
| Q1 25 | $21.0M | $28.6M | ||
| Q4 24 | $19.4M | $24.0M | ||
| Q3 24 | $19.7M | $27.5M | ||
| Q2 24 | $18.7M | $32.4M | ||
| Q1 24 | $16.3M | $17.9M |
负债/权益比LRHCTLSI
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流LRHCTLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-1.3M | $-3.7M | ||
| Q2 25 | $-1.4M | $-7.3M | ||
| Q1 25 | $-3.5M | $-4.5M | ||
| Q4 24 | $-1.1M | $-5.7M | ||
| Q3 24 | $-591.6K | $-10.8M | ||
| Q2 24 | $-803.1K | $-13.4M | ||
| Q1 24 | $-538.3K | $-10.9M |
自由现金流LRHCTLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率LRHCTLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度LRHCTLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
现金转化率LRHCTLSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
TLSI
暂无分部数据
